샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941508

프리필드 시린지 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 재료별, 용도별, 유통 채널별, 지역별, 부문 예측(2026-2033년)

Prefilled Syringes Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Material (Glass Syringes, Plastic Syringes), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

프리필드 시린지 시장 개요

세계의 프리필드 시린지 시장 규모는 2025년 87억 2,000만 달러로 추정되며, 2033년에 181억 2,000만 달러에 이를 것으로 예측됩니다.

2026-2033년까지 연평균 9.7%의 성장률을 보일 것으로 예측됩니다. 고령화 사회가 진행됨에 따라 수많은 만성질환의 초기 진단 및 치료에 있어 프리필드시린지 수요가 증가하고 있습니다.

65세 이상은 심장병, 천식, 감기, 독감, COPD(만성폐쇄성폐질환), 당뇨병, 기타 질병 등 심각한 건강 문제가 발생할 위험이 높은 것으로 알려져 있습니다. 이는 노화로 인해 면역체계가 약화되어 각종 질병에 대한 개인의 감수성이 높아지기 때문입니다.

고령화 인구 증가와 이에 따른 만성질환의 부담이 입원율을 높이고 있습니다. CDC에 따르면 65세 이상 성인은 심장병, COPD, 당뇨병, 암, 신경질환, 기타 만성질환에 걸릴 확률이 높다고 합니다. 이러한 질환을 앓고 있는 환자들은 응급 및 비응급 입원 서비스나 수술이 필요합니다. 전 세계적으로 만성질환의 유병률 증가가 시장 성장을 견인하는 주요 요인으로 작용할 것으로 예측됩니다. 항균제 내성, 건강하지 못한 운동 부족, 담배와 알코올 섭취 등의 요인이 비감염성 질환(NCD) 증가에 기여하고 있습니다. 예를 들어, 2023년 9월 WHO가 발표한 자료에 따르면, 연간 약 4,100만 명이 NCD로 인해 목숨을 잃고 있으며, 이는 전 세계 전체 사망자 수의 74%에 해당합니다. 이러한 요인들은 시장에서 프리필드시린지 수요를 견인할 것으로 예측됩니다. 사전 충전된 멸균수 주사기는 약품 조제, 카테터 세척, 상처 세척 등 의료 현장에서 사용이 증가하고 있습니다. 수작업 조제가 필요 없어 오염 위험을 줄여 효율적인 임상 워크플로우를 지원하고 환자 안전 향상에 기여합니다.

바늘 찔림 사고(NSI)란 바늘 끝에 의한 경피 천자 상처를 말합니다. 주사기 사용, 취급, 분해, 폐기 시 발생할 수 있습니다. 바늘에 찔리는 사고의 높은 발생률과 관련 심각한 결과 때문에 의료진은 안전장치가 있는 주사기를 사용하도록 요구하고 있으며, 이는 예측 기간 동안 시장 확대에 기여할 것으로 예측됩니다. NSI 발생에 관여한 가장 흔한 의료기기는 정맥 캐뉼라(33.0%), 피하주사침(18.7%)이 그 뒤를 이었습니다. NSI의 절반 이상(52.7%)은 날카로운 의료기기 사용 중에 발생하며, 22.0%는 사용 후 및 폐기 전 단계에서 발생합니다. 부상의 약 42.9%가 병실에서 발생했습니다.

또한, 안전하지 않은 주사는 농양, 패혈증, 신경 손상, 출혈열을 유발할 수 있습니다. 환자와 의료진 모두 바늘에 찔리는 사고에 대한 우려가 높아지면서 시장 성장을 견인하는 주요 요인 중 하나가 될 것으로 예측됩니다. 예를 들어, 샤프스 테크놀로지는 업계 최고 수준의 일회용 스마트 안전 주사기 제품 특허를 획득했습니다. 같은 해, 회사는 헝가리에 위치한 Safeguard Medical의 주사기 제조 시설 인수를 발표했습니다. 최근 제약기업의 동향은 안전한 주사 시행을 보장하고 오염 가능성을 최소화할 수 있을 것으로 기대됩니다. 이중 챔버형 프리필드시린지는 약물과 희석제를 별도로 보관하고 투여 직전에 혼합할 수 있어 안전한 주사 시술을 더욱 돕습니다. 이를 통해 취급 공정을 줄이고 오염 위험을 줄일 수 있습니다. 이 설계는 특히 동결건조 제제 및 생물학적 제제에서 유용하며, 약물의 안정성, 용량 정확도 및 전체 환자의 안전성을 향상시킵니다.

이러한 요인에 더해 미국 FDA 등 규제 당국의 프리필드시린지 승인 건수 증가와 시장 확대가 산업의 적극적인 성장에 기여할 것으로 예측됩니다. 예를 들어, 2022년 9월에는 Owen Mumford의 자회사인 Owen Mumford Pharmaceutical Services가 프리필드 주사기용 안전장치 '1mL UniSafe'에 대해 아시아 지역에서 복합제품으로 승인을 획득했습니다. 또한, 1mL UniSafe는 유럽에서도 규제 당국의 승인을 받았으며, 현재 류마티스 관절염 치료제와 복합제로 시판되고 있습니다. 이 안전장치는 프리필드시린지를 위한 획기적인 스프링리스 특허 안전장치로, 제약회사와 환자에게 다양한 이점을 제공합니다. 이러한 발전으로 인해 예측 기간 동안 프리필드시린지에 대한 수요가 증가할 것으로 예측됩니다.

이 보고서는 2021년부터 2033년까지 각 하위 부문의 최신 산업 동향 분석과 함께 세계, 지역 및 국가별 매출 성장 예측을 제공합니다. 이 연구에서 Grand View Research는 유형, 재료, 용도, 유통 채널, 지역에 따라 세계 프리필드시린지 시장 보고서를 세분화했습니다.

  • 유형별 전망(매출액, 백만 달러, 2021-2033년)
  • 일회용
  • 재사용 가능
  • 재료별 전망(매출, 100만 달러, 2021-2033년)
  • 유리 주사기
  • 플라스틱 주사기
  • 용도별 전망(매출, 100만 달러, 2021-2033년)
  • 백신과 예방접종
  • 아나필락시스
  • 류마티스 관절염
  • 당뇨병
  • 자가면역질환
  • 종양학
  • 기타
  • 유통 채널별 전망(매출, 100만 달러, 2021-2033년)
  • 병원
  • 통신판매 약국
  • 외래수술센터
  • 지역별 전망(매출액, 100만 달러, 2021-2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 덴마크
    • 스웨덴
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 태국
    • 호주
    • 인도
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

자주 묻는 질문

  • 프리필드 시린지 시장 규모는 어떻게 예측되나요?
  • 프리필드 시린지 수요 증가의 주요 원인은 무엇인가요?
  • 바늘 찔림 사고(NSI)의 발생 원인은 무엇인가요?
  • 프리필드 시린지의 안전성을 높이기 위한 기술적 발전은 무엇인가요?
  • 프리필드 시린지 시장의 규제 동향은 어떤가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 프리필드 시린지 시장 변수, 동향과 범위

제4장 프리필드 시린지 시장 : 유형별, 추정 및 동향 분석

제5장 프리필드 시린지 시장 : 재료별, 추정 및 동향 분석

제6장 프리필드 시린지 시장 : 용도별, 추정 및 동향 분석

제7장 프리필드 시린지 시장 : 유통 채널별, 추정 및 동향 분석

제8장 프리필드 시린지 시장 : 지역별, 추정 및 동향 분석

제9장 경쟁 구도

LSH 26.03.11

Prefilled Syringes Market Summary

The global prefilled syringes market size was estimated at USD 8.72 billion in 2025 and is projected to reach USD 18.12 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. The growing elderly population has led to an increase in the demand for prefilled syringes for the primary diagnosis and treatment of numerous chronic health ailments.

It has been recognized that people above 65 years of age are at a higher risk of developing severe health problems, such as heart disease, common asthma, cold & flu, COPD, diabetes, and other medical conditions. This is because aging weakens the immune system and increases an individual's susceptibility to various disorders.

The rising geriatric population and its associated burden of chronic conditions are propelling hospital admission rates. According to the CDC, adults aged 65 years & above are more likely to suffer from heart disease, COPD, diabetes, cancer, neurological problems, and other chronic illnesses. Patients with such illnesses require emergency & nonemergency hospital services and surgeries. The rising prevalence of chronic diseases globally is a key factor expected to drive market growth. Factors such as antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption are contributing to the rising prevalence of Non-communicable Diseases (NCDs). For instance, as per WHO data published in September 2023, around 41 million people succumb to NCDs annually, corresponding to 74% of all deaths worldwide. These factors are expected to drive the demand for prefilled syringes in the market. Prefilled sterile water syringes are increasingly used in healthcare settings for drug reconstitution, catheter flushing, and wound irrigation, as they eliminate manual preparation and reduce contamination risks, thereby supporting efficient clinical workflows and improving patient safety.

Needle-stick Injuries (NSIs) are percutaneous piercing wounds caused by needle tips. These injuries can occur while using, handling, disassembling, or disposing of syringes. The high incidence rate of NSIs and associated consequences is prompting healthcare professionals to use syringes with a safety mechanism. This is expected to boost the market over the forecast period. An intravenous cannula (33.0%) followed by a hypodermic needle (18.7%) were the most common devices involved in most NSIs. More than half of NSIs occurred during the use of sharp devices (52.7%), while 22.0% occurred after use and before disposal. About 42.9% of injuries happened in the patient room.

Furthermore, unsafe injections can lead to abscesses, septicemia, nerve damage, and hemorrhagic fevers. The rise in concerns regarding NSIs among both patients and healthcare professionals is one of the major factors expected to drive market growth. For instance, Sharps Technology, Inc. patented the best-in-class, single-use smart safety syringe products. In the same year, the company announced the acquisition of Safeguard Medical's syringe manufacturing facility in Hungary. These recent developments by pharmaceutical companies are expected to ensure safe injection practices, minimizing the chances of contamination. Double-chamber prefilled syringes further support safe injection practices by allowing the drug and diluent to be stored separately and mixed just before administration, reducing handling steps and contamination risk. This design is especially beneficial for lyophilized drugs and biologics, improving drug stability, dosing accuracy, and overall patient safety.

In addition to these factors, the growing number of approvals for prefilled syringes by regulatory bodies, such as the U.S. FDA, along with market expansion, is predicted to contribute to industry expansion actively. For instance, in September 2022, Owen Mumford Pharmaceutical Services, a company of Owen Mumford Ltd., received approval as a combination product in Asia for their safety device, 1mL UniSafe, for prefilled syringes. Moreover, the 1mL UniSafe has received regulatory approval in Europe, and the medicine is currently available on the market as a combination product with a rheumatoid arthritis drug. This safety device is a revolutionary, spring-free, patented safety mechanism for prefilled syringes that delivers a variety of benefits to pharmaceutical firms and their patients. Such developments are anticipated to increase the demand for prefilled syringes over the forecast period.

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global prefilled syringes market report based on type, material, application, distribution channel, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposable
  • Reusable
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Glass Syringes
  • Plastic Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccines and immunizations
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Autoimmune diseases
  • Oncology
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Material
    • 1.2.3. Application
    • 1.2.4. Distribution Channel
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Material Outlook
    • 2.2.3. Application Outlook
    • 2.2.4. Distribution Channel Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Prefilled Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Prefilled Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Prefilled Syringes Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Prefilled Syringes Market: Type Movement Analysis
  • 4.3. Prefilled Syringes Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 4.5. Disposable
    • 4.5.1. Disposable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reusable
    • 4.6.1. Reusable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Prefilled Syringes Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Prefilled Syringes Market: Material Movement Analysis
  • 5.3. Prefilled Syringes Market by Material Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 5.5. Glass Syringes
    • 5.5.1. Glass Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Plastic Syringes
    • 5.6.1. Plastic Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Prefilled Syringes Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Prefilled Syringes Market: Application Movement Analysis
  • 6.3. Prefilled Syringes Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 6.5. Vaccines and Immunizations
    • 6.5.1. Vaccines and Immunizations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Anaphylaxis
    • 6.6.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Rheumatoid Arthritis
    • 6.7.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Diabetes
    • 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Autoimmune Diseases
    • 6.9.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Oncology
    • 6.10.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Prefilled Syringes Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Prefilled Syringes Market: Distribution Channel Movement Analysis
  • 7.3. Prefilled Syringes Market by Distribution Channel Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Mail Order Pharmacies
    • 7.6.1. Mail Order Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Ambulatory Surgery Centers
    • 7.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Prefilled Syringes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Prefilled Syringes Market Movement Analysis
  • 8.3. Prefilled Syringes Market: Regional Estimates & Trend Analysis by Technology & Application
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 8.5. North America
    • 8.5.1. North America Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. U.S. Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Canada Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. Mexico Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Europe
    • 8.5.6. Europe Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. UK
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. UK Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Germany
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. Germany Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. France
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement scenario
      • 8.5.9.5. France Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.10. Italy
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Framework
      • 8.5.10.4. Reimbursement scenario
      • 8.5.10.5. Italy Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.11. Spain
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Framework
      • 8.5.11.4. Reimbursement scenario
      • 8.5.11.5. Spain Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.12. Denmark
      • 8.5.12.1. Key Country Dynamics
      • 8.5.12.2. Competitive Scenario
      • 8.5.12.3. Regulatory Framework
      • 8.5.12.4. Reimbursement scenario
      • 8.5.12.5. Denmark Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.13. Sweden
      • 8.5.13.1. Key Country Dynamics
      • 8.5.13.2. Competitive Scenario
      • 8.5.13.3. Regulatory Framework
      • 8.5.13.4. Reimbursement scenario
      • 8.5.13.5. Sweden Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.14. Norway
      • 8.5.14.1. Key Country Dynamics
      • 8.5.14.2. Competitive Scenario
      • 8.5.14.3. Regulatory Framework
      • 8.5.14.4. Reimbursement scenario
      • 8.5.14.5. Norway Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Japan Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. China Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. India Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement scenario
      • 8.6.6.5. Australia Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement scenario
      • 8.6.7.5. Thailand Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Brazil Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Argentina Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. South Africa Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. Saudi Arabia Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. UAE Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement scenario
      • 8.8.5.5. Kuwait Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Becton, Dickinson and Company (BD)
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Gerresheimer AG
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. SCHOTT Pharma
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Stevanato Group
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Nipro Corporation
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Terumo
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. MedXL Inc
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. West pharmaceuticals
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. Fresenius Kabi
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. B. Braun SE
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제